Business
BioSpectrum Asia
India Health Fund supports D-Nome to bolster molecular TB screening in India
India Health Fund (IHF), a Tata Trusts initiative, is poised to transform tuberculosis (TB) screening at scale by enabling the development of the world's most affordable molecular screening tool for TB.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
BioOra and Octane Biotech sign LoI to expand cell therapy manufacturing using Cocoon Platform
BioOra, a commercialstage cell therapy company advancing CAR-T therapies for cancer patients, & Canadabased Octane Biotech Inc., an Octane Medical Group Company, has announced the signing of a Letter of Intent (LOI) to collaborate on the co-development & deployment of advanced cell therapies using the Cocoon automated cell therapy manufacturing platform.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
NTU and NHG Health partner to advance healthcare education in Singapore
NHG Health's inaugural E3 (Educate, Elevate, Evolve) conference, held recently, was marked by a new partnership with Nanyang Technological University (NTU) Singapore, signalling a significant step in advancing healthcare education through interdisciplinary collaboration.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Gene Solutions introduces non-invasive prenatal screening technology triSure in Taiwan
Singapore-based startup Gene Solutions has introduced triSure, a revolutionary non-invasive prenatal screening technology.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
How FemTech Spurt in APAC is Redefining Healthcare
Despite representing half the global population, women's health has historically received only a fraction of healthcare innovation and investment.
4 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
China's Colossal Ageing Population and Low Birth Rate Challenge
China's recent policy initiatives pertaining to long-term care insurance, maternity insurance expansion, and primary healthcare reform reflect a coordinated attempt to address deep structural demographic challenges—most notably 'rapid population ageing' and declining birth rates.
2 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
"We need to prioritise research as several common AYA cancers are significantly under-studied in Asian populations"
At the SingHealth Presidents' Scientific and Partners in Social-care (SPSOC) Conference, Assistant Professor Eileen Poon, Senior Consultant in Medical Oncology at the National Cancer Centre Singapore (NCCS) delivered an enlightening presentation.
7 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Shimadzu Scientific Instruments opens laboratory in San Francisco Bay Area
Shimadzu Scientific Instruments (SSI) has opened its new research and development (R&D) facility in South San Francisco, California, US.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
"Building a lean team with deep operational expertise increases likelihood of success in rare disease drug development"
More than 300 million people worldwide are impacted by over 10,000 rare diseases, i.e. more than cancer and AIDS combined.
5 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Qiagen expands into bloodstream infection syndromic testing with new rapid QIAstat-Dx panel
Qiagen N.V. has announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Royalty Pharma on-boards Kenneth Sun as Senior Vice President and Head of Asia
US-based Royalty Pharma ple has announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Waters launches omniDAWN Multi-Angle Light Scattering (MALS) Photometer
US-based Waters Corporation has announced the launch of the Waters omniDAWN Multi-Angle Light Scattering (MALS) Photometer, part of the Wyatt Technology Portfolio.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
South Korea's Cell and Gene Therapy Surge
South Korea's cell and gene therapy (CGT) landscape is highly dynamic, as observed from regulatory approvals, clinical development, and manufacturing activity.
5 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Agilent unveils BioTek Cytation 9 cell imaging multimode reader
US-based Agilent Technologies has announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and high-content cell imaging in a single platform.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
BlinkLab secures A$17.5 M for launch of autism diagnostic aid
Australia based BlinkLab, a leading digital healthcare startup focused on the development of artificial intelligence (AI)-powered diagnostic technology, has successfully completed an oversubscribed Placement of ordinary shares to sophisticated and institutional investors; raising a total of A$17.5 million (before costs) at a price of A$0.65 per ordinary share.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Neurophet signs MoU with Alzheimer's Network for Treatment and Diagnostics
South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, has signed a Memorandum of Understanding (MOU) with the Alzheimer's Network for Treatment and Diagnostics (ALZ-NET).
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Meiji Pharma Asia commences operations in Singapore
Japan's Meiji Seika Pharma has announced that its local subsidiary, Meiji Pharma Asia has commenced operations in Singapore on April 1, 2026.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Dai Nippon Printing establishes second overseas R&D base in IIT Hyderabad, India
Japan's Dai Nippon Printing (DNP) has established a new research and development base in Telangana, India to advance and reinforce its global R&D strategy.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Chinese University of Hong Kong establishes Women in Science and Medicine Academy
As global competition for research talent accelerates and innovation ecosystems rapidly evolve, the development and retention of scientific talent have become defining priorities for leading higher education and medical institutions worldwide.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Thermo Fisher builds global biobank leadership through collaboration with PRECISE-SG100K Singapore
US-based Thermo Fisher Scientific Inc. has announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, one of the region's most ambitious & diverse population-scale biobank initiatives.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Shionogi makes investment in Restore Vision to develop visual restoration gene therapy
Shionogi & Co. has made an equity investment in Restore Vision Inc, a Tokyobased startup developing innovative technologies in the field of ophthalmology.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Pacific OneHealth commits Rs 300 Cr to build largest micro-hospital chain in North India
Pacific OneHealth, a healthcare venture backed by the Pacific Malls Group, has announced a committed investment of Rs 300 crore to build the largest integrated community micro-hospital chain in North India.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Insilico Medicine signs $2.75 B global R&D collaboration with Eli Lilly
Insilico Medicine, a Hong Kong-based clinicalstage biotechnology company powered by generative artificial intelligence (AI) and automation, has announced a drug discovery collaboration with Eli Lilly and Company that uses Insilico's AI engine to accelerate the discovery and development of novel therapeutics across multiple therapeutic areas.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
China Budget 2026: Healthcare and Innovation Take Centre Stage
China's 2026 budget marks the beginning of the 15th Five-Year Plan, placing technology and innovation at the centre of growth across sectors, including life sciences.
3 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Dr In-Kyu Yoon steps in as DDG of Integrated Development and Pandemic Readiness at IVI
South Korea-based International Vaccine Institute (IVI) has announced that Dr In-Kyu Yoon has been appointed Deputy Director General (DDG) of the newly established Integrated Development and Pandemic/Outbreak Readiness unit, effective April 2026.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Harbour BioMed ropes in Dr Adam Zong as President
Harbour BioMed, a US and China-based biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, has announced the appointment of Dr Adam Zong as President.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Why Future of Australian Healthcare Rests on Bridging Connected Care Gap
Connected care represents the cornerstone of healthcare's future within Australia—where seamless information flow will drive enhanced patient outcomes through more accessible and actionable data.
4 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
AI and Prevention Drive Singapore's Healthcare Strategy in Budget 2026
On February 12, the Singapore government presented its 2026 National Budget, positioning it as a first step toward securing the country's future in a changing global environment.
4 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Avantor inks strategic collaboration with Parafilm to serve Indian lab consumables market
Avantor, Inc., a leading life science tools company and global provider of missioncritical products and services to the life sciences and advanced technology industries, has announced that Avantor India has been appointed the exclusive distributor of Amcor Parafilm M sealing wrap products in India.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Otsuka Pharma buys Transcend Therapeutics for $1.2 B
Japan-based Otsuka Pharmaceutical and US-based startup Transcend Therapeutics have entered into an agreement, under which Otsuka, through its wholly owned subsidiary Otsuka America, Inc., will fully acquire Transcend.
1 min |